The following policies were recently reviewed for annual update. The full text of these policies is available in the Provider section of bcbsri.com.            

• • Absorbable Nasal Implants for the Treatment of Nasal Valve Collapse
  • Actigraphy
  • Autism Spectrum Disorder Mandate – Updated with 2019 codes
  • Autologous Platelet Derived Growth Factors
  • Bone Mineral Density Studies
  • Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
  • Genetic Testing for Diagnosis and Management of Mental Health Conditions
  • Injectable Fillers
  • Lysis of Epidural Adhesions
  • Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders
  • Microvolt T-wave Alternans (MTWA)
  • Minimally Invasive Intradiscal and Annular Procedures for Back Pain
  • Non-Wearable Automatic External Defibrillator
  • Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy
  • PathFinderTG® Molecular Testing
  • Patient-Controlled End of Range Motion Stretching Devices
  • Pediatric Dental Essential Services
  • Preventive Services: BlueCHiP for Medicare
  • Proprietary Laboratory Analyses (PLA)
  • Proteogenomic Testing for Patients with Cancer
  • Psychological and Neuropsychological Testing - Updated with 2019 codes
  • Saturation Biopsy in the Diagnosis, Staging and Management of Prostate Cancer
  • Serum Tumor Markers for Breast and Gastrointestinal Malignancies
  • Telemedicine Services Effective 01|01|2019
  • Total Arthroplasty Hip-Knee
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Transpupillary Thermotherapy for Treatment of Choroidal Neovascularization
  • Ultrasonographic Measurement of Carotid Intima-Medical Thickness as an Assessment of subclinical Atherosclerosis
  • Vertebral Fracture Assessment